Is Publishing in Impact Factor Journals Worth It in 2025-26?

What the impact factor actually measures

The journal impact factor (JIF) is a citation-based metric: roughly, the average number of citations received in a given year by articles a journal published in the previous two years. It remains one of the most widely used proxies for journal prestige and academic influence ^[1][2][3]. Because hiring committees, promotion panels, and funding bodies still lean on it, publishing in high-IF journals continues to be a strategic move for career advancement and recognition ^[4][5].

But a crucial distinction is often lost: the IF describes the journal, not your individual article. A single paper in a high-IF venue may go uncited for years, while a paper in a modest journal can quietly accumulate citations over a decade ^[2].

The short answer: is it worth it?

Impact-factor trends in 2025-26

Impact factors are not static. Biomedical journals saw a sharp surge during the COVID-19 pandemic as research output and citations spiked — followed by a measurable decline as attention shifted away from pandemic topics ^[1][6]. Meanwhile, some journals have deliberately lifted their IFs through editorial strategy, particularly by commissioning review articles, which historically attract more citations than original research ^[7].

Limitations and critiques of the impact factor

The academic community is increasingly vocal about the IF’s blind spots. Critics argue that an overemphasis on the metric fuels the commercialization of scholarly publishing and can crowd out research quality and disciplinary diversity ^[3]. Empirically, the IF is a poor predictor of an individual article’s long-term impact: one cross-journal analysis found no reliable link between a journal’s IF and the eventual citation trajectory of its articles ^[2].

In short, a high IF tells you a journal is, on average, well-cited recently — it does not guarantee your specific contribution will be read, cited, or remembered.

Open access, visibility & equity

Open access (OA) publishing continues to gain ground, promising broader visibility and accessibility — a major draw for researchers who want real-world reach. Yet the evidence is nuanced: some studies report that OA articles are cited less frequently than subscription articles in certain fields, which can paradoxically dampen a journal’s IF ^[7][8].

Equity remains an unresolved problem. Bibliometric analyses document persistent regional and gender disparities in high-impact publishing: non-Western regions and women are underrepresented in both authorship and editorial leadership ^[9][10][11]. For the field to mature, where we publish — and who gets to decide what is published — both matter.

Alternative metrics worth knowing

If the IF is a blunt instrument, what sharper tools exist? Researchers and evaluators are increasingly turning to complementary metrics that capture influence more precisely ^[9][12]:

Beyond metrics, journals are using special issues and thematic collections to raise visibility and relevance without sacrificing impact ^[13] — a useful signal when scouting where to submit.

A practical decision framework for 2025-26

Use this quick checklist before submitting:

Conclusion

Publishing in impact-factor journals in 2025-26 is still worth it — particularly for career advancement, funding, and recognition. But the IF is a starting point, not a destination. Researchers who pair journal prestige with open-access reach, awareness of alternative metrics, and a clear-eyed view of equity will make stronger, more durable publishing decisions. Balance prestige, accessibility, and genuine long-term impact, and the metric works for you rather than the other way around.

Frequently asked questions

References